Rainbow Children’s Medicare reports 23% revenue growth in Q2 FY27

Rainbow Children’s Medicare Limited announced a robust performance for the second quarter of FY27, with revenue growing by 23% year-on-year to ₹5,480 million. The company also saw double-digit growth in EBITDA and Profit After Tax. New hospitals in Nellore and Guntur commenced operations, strengthening its Andhra Pradesh network and contributing to overall growth.

Rainbow Children’s Medicare Reports Strong Q2 FY27 Financials

Rainbow Children’s Medicare Limited (RCML) has announced its unaudited financial results for the quarter ended September 30, 2026, showcasing a significant 23% year-on-year revenue growth. The company reported total revenue of ₹5,480 million for Q2 FY27, up from ₹4,448 million in the same period last year. This growth was driven by healthy patient volumes and improved performance across its network.

Key Financial Highlights

The company’s EBITDA saw a substantial increase of 14.2%, reaching ₹1,700 million in Q2 FY27, compared to ₹1,489 million in Q2 FY26. Profit After Tax (PAT) also demonstrated a positive trend, growing by 10.9% to ₹839 million from ₹756 million in the prior year’s quarter. These results highlight the company’s steady financial progress despite seasonal factors affecting volumes.

Network Expansion and Operational Updates

Rainbow Children’s Medicare has further strengthened its presence in Andhra Pradesh with the commencement of operations at its newly acquired 70-bed hospital in Nellore and a new 50-bed hospital in Guntur. These additions expand the company’s network along the coast. Plans are also underway to establish a specialty pediatric hospital in the new capital city of Amaravati.

In its operational highlights, the company reported an 18% increase in operational beds to 1,910. IP Discharges grew by 15% and OP Consultations saw a 19% increase year-on-year. The company’s focus remains on improving occupancy, maintaining efficient patient throughput, and continuing momentum across both mature and new hospitals.

Strategic Outlook

Dr. Ramesh Kancharla, Chairman & Managing Director, stated, “This quarter’s performance reflects continued demand for specialized pediatric and women’s healthcare, as well as steady progress across our hospitals. Our expansion in Nellore and Guntur strengthens our presence across Andhra Pradesh, while the proposed Amaravati hospital is now in the project planning phase.” Mr. Abarali Dalal, CEO, added, “We have delivered an exceptional 20%+ year-on-year revenue growth for the third consecutive quarter, reflecting the consistency of our performance despite seasonal softness.”

The company maintained a strong balance sheet with cash, cash equivalents, fixed deposits, and mutual fund investments totaling ₹5,428 million as of September 30, 2026, which will support ongoing capital expenditure and acquisition plans.

Source: BSE

Previous Article

Central Bank of India announces senior management change

Next Article

Neogen Chemicals reports Q2 FY27 results and approves related party transactions